Effects of p53 Mutation on Tumor Radiosensitivity Estimated by Predictive Models

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• p53 gene mutations are frequently observed across various cancers.
• These mutations are being investigated for their potential role in predicting tumor radiosensitivity.
• Understanding factors influencing radiosensitivity is crucial for optimizing cancer treatment strategies.

Purpose of the Study:

• To evaluate the impact of p53 gene mutations on predicted tumor radiosensitivity.
• To assess the relationship between p53 mutations and radiosensitivity using the intrinsic radiosensitivity index (RSI).
• To investigate the influence of p53 status and tumor microenvironment on radiosensitivity in different cancer cohorts.

Main Methods:

• Utilized The Cancer Genome Atlas (TCGA) dataset for gene expression, mutation, and clinical data.
• Calculated the intrinsic radiosensitivity index (RSI) based on the expression of 10 specific genes.
• Employed predictive models to assess tumor microenvironment status and radiosensitivity.

Main Results:

• p53 mutations were common in multiple cancer types.
• Reduced predicted radiosensitivity was observed in head and neck squamous cell carcinoma (HNSC) patients with p53 mutations.
• This association in HNSC was diminished when controlling for p16 status, suggesting p16 is a stronger predictor.
• p53 mutations did not significantly impact predicted radiosensitivity in other analyzed cancers.
• Tumor microenvironment status was not significantly affected by p53 mutations.

Conclusions:

• p53 gene status alone is not a reliable predictor of radiosensitivity in head and neck squamous cell carcinoma.
• p16 status appears to be a more significant determinant of predicted radiosensitivity in HNSC.
• Further research is needed to elucidate the complex interplay of genetic factors and tumor microenvironment in determining radiation response.